Form 4 for DXCM Dexcom

Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-10 · accession 0001093557-25-000284 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-11-10	2025-11-10	DXCM	Leach Jacob Steven	Pres, COO	P - Purchase	$55.04	+18.2K	329.2K	+6%	+$1.00M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-11-10	P	A	2,500	$55.43	331,697	D	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $55.34 to $55.55. The price above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. (F3) Included in this number are 84,537 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 8,465 of which were granted on March 8, 2023 and shall vest through March 8, 2026.
2	Common	Common Stock	2025-11-10	P	A	15,700	$54.98	329,197	D	—	—	(F1) This transaction was executed in multiple trades at prices ranging from $54.34 to $55.33. The price above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.